{"id":"sildenafil-viagra","safety":{"commonSideEffects":[{"rate":"16","effect":"Headache"},{"rate":"10","effect":"Flushing"},{"rate":"7","effect":"Dyspepsia"},{"rate":"4","effect":"Nasal congestion"},{"rate":"2","effect":"Back pain"},{"rate":"2","effect":"Myalgia"},{"rate":"3","effect":"Vision abnormalities (blue-tinted vision)"}]},"_chembl":{"chemblId":"CHEMBL1737","moleculeType":"Small molecule","molecularWeight":"666.71"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"By blocking PDE-5, sildenafil prevents the breakdown of cyclic guanosine monophosphate (cGMP), allowing cGMP to accumulate. This leads to smooth muscle relaxation in penile tissue and increased blood flow to the corpus cavernosum, facilitating erection in response to sexual stimulation. The drug works within the nitric oxide-cGMP signaling pathway.","oneSentence":"Sildenafil inhibits phosphodiesterase-5 (PDE-5) in the corpus cavernosum, increasing cyclic GMP levels and promoting smooth muscle relaxation and vasodilation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:07:55.586Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Erectile dysfunction"},{"name":"Pulmonary arterial hypertension"},{"name":"Benign prostatic hyperplasia symptoms"}]},"trialDetails":[{"nctId":"NCT03596047","phase":"NA","title":"Radial Shockwave Therapy for Erectile Dysfunction","status":"COMPLETED","sponsor":"Boston Medical Group","startDate":"2018-04-19","conditions":"Erectile Dysfunction","enrollment":80},{"nctId":"NCT07039760","phase":"EARLY_PHASE1","title":"Asciminib With or Without Sildenafil for Brain Tumors","status":"NOT_YET_RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2026-04-30","conditions":"Brain Tumor","enrollment":12},{"nctId":"NCT03142568","phase":"PHASE2","title":"Safety of Sildenafil in Premature Infants","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2018-04-02","conditions":"Bronchopulmonary Dysplasia","enrollment":109},{"nctId":"NCT07462260","phase":"PHASE2, PHASE3","title":"Sildinafil in Pulmonary Hypertension-Rheumatic Chronic Valvular Disease(RCT)","status":"RECRUITING","sponsor":"Sindh Institute of Cardiovascular Diseases","startDate":"2025-08-01","conditions":"Pulmonary Hypertension, Rheumatic Valvular Heart Disease","enrollment":100},{"nctId":"NCT05061368","phase":"PHASE2","title":"Oral Sildenafil for Exercise Capacity, Dyspnea and Cardiopulmonary Function in COPD","status":"RECRUITING","sponsor":"University of Alberta","startDate":"2022-03-01","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":160},{"nctId":"NCT06123156","phase":"PHASE3","title":"Interest of Early Erectile Rehabilitation With Sildenafil After Radiotherapy and Proctectomy for Rectal Cancer","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Rouen","startDate":"2026-03","conditions":"Rectal Cancer","enrollment":188},{"nctId":"NCT06810284","phase":"PHASE2","title":"Sildenafil Plus Hypothermia to Treat Neonatal Encephalopathy","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-10","conditions":"Hypoxic-Ischemic Encephalopathy","enrollment":24},{"nctId":"NCT04039464","phase":"PHASE3","title":"Mono vs. Dual Therapy for Pediatric Pulmonary Arterial Hypertension","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2022-08-01","conditions":"Pediatric Pulmonary Hypertension","enrollment":28},{"nctId":"NCT07391579","phase":"PHASE4","title":"Daily Tadalafil 5 mg Combined With On-Demand Sildenafil 100 mg for Treatment of Erectile Dysfunction in PDE-5I Non Responder Patients","status":"RECRUITING","sponsor":"Mansoura University","startDate":"2025-12-01","conditions":"Erectile Dysfunctions","enrollment":500},{"nctId":"NCT07377084","phase":"","title":"Metabolomics of Cancers of the Upper Aerodigestive Tract","status":"RECRUITING","sponsor":"Centre Antoine Lacassagne","startDate":"2020-11-04","conditions":"Upper AerodigestiveTract Cancer","enrollment":250},{"nctId":"NCT04447989","phase":"PHASE2","title":"Safety of Sildenafil in Premature Infants With Severe Bronchopulmonary Dysplasia","status":"COMPLETED","sponsor":"Christoph Hornik","startDate":"2021-05-27","conditions":"Bronchopulmonary Dysplasia of Newborn","enrollment":125},{"nctId":"NCT06510322","phase":"EARLY_PHASE1","title":"Sildenafil to Reduce Vascular Remodeling During Left Ventricular Assist Device Support","status":"RECRUITING","sponsor":"Montefiore Medical Center","startDate":"2025-03-12","conditions":"Vascular Diseases","enrollment":50},{"nctId":"NCT06954597","phase":"PHASE2","title":"Safety and Tolerability of TOP-N53 Applied on Digital Ulcers in Patients With Systemic Sclerosis","status":"RECRUITING","sponsor":"Topadur Pharma AG","startDate":"2025-02-04","conditions":"Digital Ulcers in Systemic Sclerosis","enrollment":15},{"nctId":"NCT04481789","phase":"PHASE1","title":"Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Males (Drug Interaction Study and Preliminary Regimen-Finding Study)","status":"COMPLETED","sponsor":"Tanabe Pharma Corporation","startDate":"2018-10-17","conditions":"Healthy Adult Subjects","enrollment":84},{"nctId":"NCT06324396","phase":"PHASE1","title":"IMProving DRug Dosing and Outcomes for Single VEntricle Patients With Fontan Associated Liver Disease","status":"RECRUITING","sponsor":"Children's Mercy Hospital Kansas City","startDate":"2024-03-01","conditions":"Fontan Circulation","enrollment":15},{"nctId":"NCT07302698","phase":"PHASE1","title":"PK and Onset of Hezkue Oral Sildenafil Suspension After Alcohol Consumption","status":"NOT_YET_RECRUITING","sponsor":"Aspargo Labs, Inc","startDate":"2026-03-15","conditions":"Healthy Volunteers","enrollment":24},{"nctId":"NCT07290400","phase":"PHASE2","title":"Effect of Moderate Alcohol on Absorption and Onset of Hezkue Sildenafil Suspension","status":"NOT_YET_RECRUITING","sponsor":"Aspargo Labs, Inc","startDate":"2026-04-15","conditions":"Erectile Dysfunction","enrollment":36},{"nctId":"NCT04565925","phase":"PHASE2","title":"Sildenafil for Treatment of Urinary Incontinence in Patients With Spinal Cord Injuries","status":"RECRUITING","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2021-07-07","conditions":"Spinal Cord Injuries, Urinary Incontinence","enrollment":24},{"nctId":"NCT07117383","phase":"PHASE1","title":"Hezkue®, Hezkue Turbo®, and Commercial Sildenafil Products in Fed Healthy Male Subject","status":"NOT_YET_RECRUITING","sponsor":"Aspargo Labs, Inc","startDate":"2026-01","conditions":"Erectile Dysfunction","enrollment":72},{"nctId":"NCT05782244","phase":"PHASE2","title":"Sildenafil for Microvasculopathy in Chronic TBI","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2024-07-02","conditions":"Traumatic Brain Injury","enrollment":160},{"nctId":"NCT07245875","phase":"NA","title":"Umbilical Cord Mesenchymal Stem Cell Secretome Administration in Severe Erectile Dysfunction Non-responsive to Sildenafil","status":"COMPLETED","sponsor":"Indonesia University","startDate":"2024-04-12","conditions":"Erectile Dysfunction, Diabetes Mellitus Type 2","enrollment":12},{"nctId":"NCT03855332","phase":"PHASE2","title":"Oxford Haemodynamic Adaptation to Reduce Pulsatility Trial","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2019-07-11","conditions":"Small Vessel Cerebrovascular Disease","enrollment":75},{"nctId":"NCT06872866","phase":"PHASE1","title":"The Objective of This Phase 1 Study is to Evaluate the Food Effect of 100 mg Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fed Versus 100 mg of Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fasted Conditions in Healthy Adult Male Subjects","status":"RECRUITING","sponsor":"Aspargo Labs, Inc","startDate":"2025-04-15","conditions":"Erectile Dysfunction","enrollment":12},{"nctId":"NCT07231185","phase":"PHASE2","title":"Phase 2 Efficacy Study of Sildenafil Products in Adult Men With Erectile Dysfunction","status":"NOT_YET_RECRUITING","sponsor":"Aspargo Labs, Inc","startDate":"2026-01","conditions":"Erectile Dysfunction","enrollment":200},{"nctId":"NCT06800092","phase":"PHASE2, PHASE3","title":"Sildenafil to Prevent and Reduce Cancer Related Cognitive Impairment","status":"NOT_YET_RECRUITING","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2026-03-15","conditions":"Cancer","enrollment":30},{"nctId":"NCT05490680","phase":"PHASE3","title":"A New Sildenafil Oral Film in Patients With Erectile Dysfunction","status":"COMPLETED","sponsor":"IBSA Institut Biochimique SA","startDate":"2024-01-26","conditions":"Erectile Dysfunction","enrollment":488},{"nctId":"NCT04797286","phase":"PHASE2","title":"Sildenafil for Early Pulmonary Vascular Disease in Scleroderma","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2021-09-20","conditions":"Scleroderma, Mildly Elevated Pulmonary Pressures","enrollment":30},{"nctId":"NCT07177326","phase":"PHASE3","title":"Combination Therapy of Tadalafil 2.5mg Plus Sildenafil 25mg Versus Tadalafil 5 mg Monotherapy for Treatment of Erectile Dysfunction: A Randomized, Placebo-Controlled Double-Blinded Cross-Over Study","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2025-10-01","conditions":"Erectile Dysfunction","enrollment":142},{"nctId":"NCT06522854","phase":"PHASE3","title":"Oral Sildenafil Citrate to Improve Maternal and Neonatal Outcomes in Low-resource Settings","status":"WITHDRAWN","sponsor":"University of Alabama at Birmingham","startDate":"2025-05-01","conditions":"Intrapartum Fetal Distress, Neonatal Asphyxia, Intrapartum Asphyxia","enrollment":""},{"nctId":"NCT06377098","phase":"PHASE3","title":"Intrapartum Sildenafil in Laboring Mothers","status":"WITHDRAWN","sponsor":"University of Alabama at Birmingham","startDate":"2025-05-01","conditions":"Neonatal Asphyxia, Intrapartum Fetal Distress, Development, Infant","enrollment":""},{"nctId":"NCT05765487","phase":"PHASE1","title":"Using Thermography to Assess the Affects of Sildenafil Cream, 3.6%","status":"COMPLETED","sponsor":"Daré Bioscience, Inc.","startDate":"2023-05-13","conditions":"Sexual Arousal Disorder","enrollment":13},{"nctId":"NCT06778330","phase":"NA","title":"The Effect of Combination of Dapagliflozin and Sildenafil in Treatment of Heart Failure Patients With Secondary Pulmonary Hypertension","status":"COMPLETED","sponsor":"Fayoum University","startDate":"2025-01-20","conditions":"Heart Failure NYHA Class II","enrollment":100},{"nctId":"NCT01347216","phase":"","title":"COMPERA / COMPERA-KIDS","status":"RECRUITING","sponsor":"Technische Universität Dresden","startDate":"2007-07-01","conditions":"Pulmonary Arterial Hypertension (PAH), Pulmonary Hypertension (PH)","enrollment":14000},{"nctId":"NCT07135037","phase":"PHASE2","title":"Comparison Between Treatments of Oligohydramnios","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2024-09-01","conditions":"Oligohydramnios","enrollment":40},{"nctId":"NCT03945812","phase":"PHASE4","title":"Platelet-Rich Plasma vs. Granulocyte Colony-Stimulating Factor vs. Placebo and Outcomes in Frozen Embryo Transfer","status":"COMPLETED","sponsor":"Wael Elbanna Clinic","startDate":"2019-06-01","conditions":"Infertility, Frozen Embryo Transfer (FET)","enrollment":665},{"nctId":"NCT05039086","phase":"","title":"Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - PDE5","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2021-09-01","conditions":"Pulmonary Arterial Hypertension","enrollment":13021},{"nctId":"NCT04344678","phase":"NA","title":"The Phosphodiesterase 5 Inhibitor Sildenafil as an Adjunct to Antidepressants in Major Depressive Disorder Patients","status":"WITHDRAWN","sponsor":"Sadat City University","startDate":"2020-01-01","conditions":"Major Depressive Disorder","enrollment":""},{"nctId":"NCT07057011","phase":"NA","title":"Therapeutic Outcomes of Selective Serotonin Reuptake Inhibitors and Phosphodiesterase-5 Inhibitors Combination Therapy Versus Monotherapy","status":"NOT_YET_RECRUITING","sponsor":"South Valley University","startDate":"2025-07-01","conditions":"Premature Ejaculation","enrollment":60},{"nctId":"NCT04356716","phase":"PHASE2","title":"Sildenafil for Treatment of Choroidal Ischemia","status":"COMPLETED","sponsor":"Columbia University","startDate":"2014-11-11","conditions":"Choroidal Ischemia, Vitelliform Macular Dystrophy, Age-related Macular Degeneration","enrollment":22},{"nctId":"NCT05741229","phase":"NA","title":"The Effect Of Nebulizied Nitroglycerin As An Adjuvant Therapy For Persistent Pulmonary Hypertension Of Newborns","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2024-01-01","conditions":"Persistent Pulmonary Hypertension of the Newborn, Echocardiography, Respiratory Disease","enrollment":80},{"nctId":"NCT03686306","phase":"PHASE3","title":"VIRTUOSE : Efficiency of Sildenafil on the Absolute Claudication Distance of Peripheral Arterial Disease Patients With Intermittent Claudication.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Rennes University Hospital","startDate":"2021-11-24","conditions":"Peripheral Artery Disease","enrollment":106},{"nctId":"NCT06715280","phase":"PHASE4","title":"Switching of Sildenafil to Riociguat in CTEPH Patients","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2024-07-25","conditions":"Chronic Thromboembolic Pulmonary Hypertension","enrollment":30},{"nctId":"NCT02983461","phase":"PHASE1","title":"Use of Sildenafil for Treatment of Urinary Incontinence","status":"ACTIVE_NOT_RECRUITING","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2017-03-10","conditions":"Urinary Incontinence","enrollment":24},{"nctId":"NCT02682147","phase":"PHASE4","title":"Functional CT Assessment of Pulmonary Arterial Dysfunction in Smoking Associated Emphysema","status":"ACTIVE_NOT_RECRUITING","sponsor":"Eric A. Hoffman","startDate":"2017-07-10","conditions":"Emphysema","enrollment":17},{"nctId":"NCT05201144","phase":"PHASE2","title":"A Trial of Phosphodiesterase-5 Inhibitor in Neonatal Congenital Diaphragmatic Hernia (TOP-CDH)","status":"RECRUITING","sponsor":"University of Utah","startDate":"2022-09-15","conditions":"Congenital Diaphragmatic Hernia, Pulmonary Hypertension","enrollment":40},{"nctId":"NCT04211272","phase":"PHASE1","title":"A 2-part Study to Investigate the Effect of Macitentan in Healthy Male Participants","status":"COMPLETED","sponsor":"Actelion","startDate":"2020-01-14","conditions":"Healthy","enrollment":47},{"nctId":"NCT04538976","phase":"PHASE4","title":"Copd Exacerbation and Pulmonary Hypertension Trial","status":"COMPLETED","sponsor":"Chronic Obstructive Pulmonary Disease Trial Network, Denmark","startDate":"2020-02-01","conditions":"Acute Exacerbation of COPD","enrollment":250},{"nctId":"NCT06875258","phase":"PHASE4","title":"PEnile ReHABilitation After Nerve Sparing Robot-assisted Radical Prostatectomy for Prostate Cancer 2.0 (PEHAB-II)","status":"RECRUITING","sponsor":"The Netherlands Cancer Institute","startDate":"2024-01-15","conditions":"Erectile Dysfunction Following Radical Prostatectomy","enrollment":198},{"nctId":"NCT06860399","phase":"PHASE1, PHASE2","title":"Vardenafil Vs Sildenafil for the Treatment of Pulmonary Hypertension of the Newborn","status":"COMPLETED","sponsor":"Damascus University","startDate":"2023-05-01","conditions":"PPHN","enrollment":55},{"nctId":"NCT06839651","phase":"PHASE1","title":"Umbilical Cord Mesenchymal Stem Cell Secretome in Severe Erectile Dysfunction Non-responsive to Sildenafil","status":"NOT_YET_RECRUITING","sponsor":"Indonesia University","startDate":"2025-04-21","conditions":"Erectile Dysfunctions","enrollment":10},{"nctId":"NCT03382106","phase":"PHASE4","title":"Smoking Cessation and Functional CT Assessment","status":"COMPLETED","sponsor":"Eric A. Hoffman","startDate":"2018-03-19","conditions":"Emphysema","enrollment":162},{"nctId":"NCT06649539","phase":"PHASE4","title":"Delayed Dose Collagenase Clostridium Histolyticum (CCH) Protocol for Men With Peyronie's Disease","status":"RECRUITING","sponsor":"Charitable Union for the Research and Education of Peyronie's Disease","startDate":"2024-10-11","conditions":"Peyronie Disease","enrollment":40},{"nctId":"NCT06178523","phase":"PHASE4","title":"Cost-effective Treatment of Unexplained Infertility","status":"COMPLETED","sponsor":"Batterjee Medical College","startDate":"2024-01-01","conditions":"Unexplained Infertility","enrollment":900},{"nctId":"NCT00433329","phase":"PHASE4","title":"Combination Therapy in Pulmonary Arterial Hypertension","status":"COMPLETED","sponsor":"Actelion","startDate":"2007-03","conditions":"Pulmonary Arterial Hypertension","enrollment":100},{"nctId":"NCT00303459","phase":"PHASE4","title":"Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH)","status":"COMPLETED","sponsor":"Actelion","startDate":"2006-05","conditions":"Pulmonary Arterial Hypertension","enrollment":334},{"nctId":"NCT00302211","phase":"PHASE3","title":"The \"VISION\" Trial: Ventavis Inhalation With Sildenafil to Improve and Optimize Pulmonary Arterial Hypertension","status":"TERMINATED","sponsor":"Actelion","startDate":"2006-02-01","conditions":"Pulmonary Hypertension","enrollment":67},{"nctId":"NCT06797479","phase":"","title":"Detection of Circulating Therapeutic Monoclonal Antibodies in Biological Samples of Gynecological Cancer Patients.","status":"NOT_YET_RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2025-03-01","conditions":"Gynecological Cancer, Immunotherapy","enrollment":12},{"nctId":"NCT06782659","phase":"PHASE1","title":"Study to Compare the Effects of Viagra® Vs Hezkue® in Healthy Fasted Male Participants.","status":"NOT_YET_RECRUITING","sponsor":"Aspargo Labs, Inc","startDate":"2025-01","conditions":"Erectile Dysfunction","enrollment":56},{"nctId":"NCT06098833","phase":"PHASE2","title":"Treatment of Neonatal Encephalopathy With Oral Sildenafil Suspension to Repair Brain Injury Secondary to Birth Asphyxia","status":"RECRUITING","sponsor":"Pia Wintermark","startDate":"2024-07-01","conditions":"Neonatal Encephalopathy","enrollment":60},{"nctId":"NCT06753981","phase":"","title":"Efficacy and Safety of Triple-targeted Drug Therapy in Treatment-naive Patients With Non-low-risk PAH: A Real-world, Multicenter Study","status":"RECRUITING","sponsor":"Qianfoshan Hospital","startDate":"2024-12-10","conditions":"Arterial Pulmonary Hypertension (PAH)","enrollment":48},{"nctId":"NCT05275725","phase":"PHASE1","title":"Finding Solutions to Thrive After Birth Asphyxia in Africa","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pia Wintermark","startDate":"2022-07-01","conditions":"Birth Asphyxia","enrollment":18},{"nctId":"NCT04912726","phase":"NA","title":"Endovenous Sildenafil Early Management in Newborns Pulmonary Hypertension","status":"WITHDRAWN","sponsor":"Universidad del Norte","startDate":"2025-01-01","conditions":"Hypertension, Pulmonary","enrollment":""},{"nctId":"NCT05196308","phase":"PHASE2","title":"Efficacy of Intracavernosal as add-on Therapy to Sildenafil 100 mg on Demand Compared to Sildenafil 100 mg on Demand for the Treatment of Erectile Dysfunction (ED) Not Sufficiently Responsive to Standard Therapy With Phosphodiesterase Type 5 Inhibitors","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2022-03-18","conditions":"Erectile Dysfunction","enrollment":226},{"nctId":"NCT04898114","phase":"PHASE1, PHASE2","title":"Nebulized Magnesium Sulfate and Sildenafil for Persistent Pulmonary Hypertension of Newborn","status":"RECRUITING","sponsor":"Sohag University","startDate":"2021-06-02","conditions":"Persistent Pulmonary Hypertension of Newborn","enrollment":40},{"nctId":"NCT06058832","phase":"NA","title":"Effects of Low-intensity Shockwave Therapy Versus Kegel Exercises on Arteriogenic Erectile Dysfunction in DM Patients","status":"COMPLETED","sponsor":"Cairo University","startDate":"2024-01-05","conditions":"Sexual Dysfunction, Shock Wave","enrollment":90},{"nctId":"NCT04985929","phase":"PHASE2","title":"The Impact of Sildenafil on the Pulmonary Circulation in Healthy Trained and Untrained Humans","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2021-07-01","conditions":"Healthy","enrollment":26},{"nctId":"NCT04039087","phase":"PHASE2, PHASE3","title":"Sildenafil Exercise: Role of PDE5 Inhibition","status":"COMPLETED","sponsor":"National Jewish Health","startDate":"2019-09-05","conditions":"Cystic Fibrosis","enrollment":26},{"nctId":"NCT06562036","phase":"NA","title":"Efficacy of Milrinone With Sildenafil in Persistent Pulmonary Hypertension in Children","status":"COMPLETED","sponsor":"Muhammad Aamir Latif","startDate":"2023-12-01","conditions":"Persistent Pulmonary Hypertension of the Newborn","enrollment":42},{"nctId":"NCT06565728","phase":"PHASE1","title":"Vitamin D Versus Sildenafil Citrate in Fetal Growth Restriction","status":"COMPLETED","sponsor":"Cairo University","startDate":"2022-11-03","conditions":"Fetal Growth Retardation","enrollment":99},{"nctId":"NCT06527729","phase":"EARLY_PHASE1","title":"A Novel Formulation of Sildenafil-loaded Nanocarriers for Treatment of Alopecia Areata","status":"COMPLETED","sponsor":"Assiut University","startDate":"2021-07-01","conditions":"Alopecia Areata","enrollment":28},{"nctId":"NCT01817751","phase":"PHASE2","title":"Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2013-04-11","conditions":"Glioblastoma, Recurrent Adult Brain Neoplasm, Malignant Glioma","enrollment":47},{"nctId":"NCT04169191","phase":"PHASE1","title":"Sildenafil to Repair Brain Injury Secondary to Birth Asphyxia","status":"ACTIVE_NOT_RECRUITING","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2019-09-19","conditions":"Birth Asphyxia","enrollment":20},{"nctId":"NCT03199612","phase":"EARLY_PHASE1","title":"Sildenafil To Prevent Clot","status":"COMPLETED","sponsor":"Montefiore Medical Center","startDate":"2019-06-03","conditions":"Thrombosis, Hemolysis","enrollment":20},{"nctId":"NCT06237751","phase":"NA","title":"Preoperative Sildenafil Administration for Hepatectomy","status":"RECRUITING","sponsor":"First People's Hospital of Chenzhou","startDate":"2024-02-01","conditions":"Central Venous Pressure, Hepatectomy, Hemodynamics Instability","enrollment":16},{"nctId":"NCT04122105","phase":"NA","title":"PDE5i Use in Renal Transplant Recipients","status":"WITHDRAWN","sponsor":"University of British Columbia","startDate":"2021-04-01","conditions":"Renal Transplant Failure","enrollment":""},{"nctId":"NCT05946681","phase":"","title":"Sildenafil Citrate to Improve Maternal and Neonatal Outcomes in Low-resource Settings","status":"COMPLETED","sponsor":"NICHD Global Network for Women's and Children's Health","startDate":"2023-05-16","conditions":"Fetal Distress, Perinatal Asphyxia, Birth Asphyxia","enrollment":1017},{"nctId":"NCT02421068","phase":"","title":"Population PK/PD of Off Label Drugs in Premature Neonates","status":"COMPLETED","sponsor":"Sinno H.P. Simons","startDate":"2014-08","conditions":"Premature Birth","enrollment":246},{"nctId":"NCT06317805","phase":"PHASE4","title":"Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients","status":"RECRUITING","sponsor":"AOP Orphan Pharmaceuticals AG","startDate":"2023-12-06","conditions":"Pulmonary Arterial Hypertension","enrollment":110},{"nctId":"NCT06289881","phase":"PHASE1","title":"Sildenafil 100 mg Tablets Relative to Viagra 100 mg Tablets","status":"UNKNOWN","sponsor":"Bio-innova Co., Ltd","startDate":"2025-02-04","conditions":"Healthy Subjects","enrollment":36},{"nctId":"NCT04058132","phase":"PHASE2","title":"Cerebrovascular Reactivity Assessed With fNIRS as a Biomarker of TCVI After Acute Traumatic Brain Injury in Military","status":"TERMINATED","sponsor":"Uniformed Services University of the Health Sciences","startDate":"2019-08-09","conditions":"Traumatic Brain Injury","enrollment":1},{"nctId":"NCT02284737","phase":"PHASE4","title":"A Study to Investigate the Efficacy of PADN to Improved Functional Capacity and Hemodynamics in Patients With PAH","status":"TERMINATED","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2014-11-28","conditions":"Pulmonary Arterial Hypertension","enrollment":100},{"nctId":"NCT04770155","phase":"EARLY_PHASE1","title":"Vascular Dysfunction in Black Individuals: Roles of Nitric Oxide and Endothelin-1","status":"TERMINATED","sponsor":"University of Mississippi Medical Center","startDate":"2021-05-27","conditions":"Vascular Function, Racial Disparity","enrollment":8},{"nctId":"NCT05889455","phase":"NA","title":"Effect of Sildenafil in Individuals With Migraine Pretreated With Erenumab","status":"COMPLETED","sponsor":"Danish Headache Center","startDate":"2023-04-20","conditions":"Migraine Without Aura","enrollment":16},{"nctId":"NCT06064448","phase":"PHASE4","title":"Clinical Observation of Ningmitai Capsule in Treating Chronic Pelvic Pain Syndrome With Erectile Dysfunction","status":"COMPLETED","sponsor":"Xintian Pharmaceutical","startDate":"2019-03-19","conditions":"Chronic Prostatitis With Chronic Pelvic Pain Syndrome, Erectile Dysfunction","enrollment":254},{"nctId":"NCT05684289","phase":"PHASE1","title":"A Study Investigating the Safety, Tolerability, Drug Levels and Drug Effect of BMS-986278 in Healthy Adult Participants (Part 1) and Japanese Participants (Part 2)","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2023-01-03","conditions":"Healthy Participants","enrollment":61},{"nctId":"NCT00871065","phase":"PHASE2","title":"Safety Study of Sildenafil in Treatment of Cerebral Aneurysm Vasospasm","status":"WITHDRAWN","sponsor":"University of Nebraska","startDate":"2008-07","conditions":"Cerebral Vasospasm, Subarachnoid Hemorrhage","enrollment":""},{"nctId":"NCT03945643","phase":"EARLY_PHASE1","title":"Is Blood Flow Through IPAVA and PFO Related to Breath-hold and SCUBA Diving-induced Pulmonary Hypertension?","status":"COMPLETED","sponsor":"University of Oregon","startDate":"2019-07-01","conditions":"Patent Foramen Ovale, Intrapulmonary Arteriovenous Anastamosis","enrollment":82},{"nctId":"NCT05971667","phase":"PHASE2, PHASE3","title":"Effect of Tadalafil, Sildenafil and Pentoxyfylline on Frozen Embryo Transfer Outcomes","status":"UNKNOWN","sponsor":"Beni-Suef University","startDate":"2023-07-30","conditions":"IVF","enrollment":200},{"nctId":"NCT05951413","phase":"PHASE2, PHASE3","title":"The Effect of Sildenafil Citrate on Frozen Embryo Transfer Cycles","status":"UNKNOWN","sponsor":"Beni-Suef University","startDate":"2023-06-30","conditions":"IVF","enrollment":110},{"nctId":"NCT00793338","phase":"PHASE4","title":"Evaluation of Sildenafil for the Treatment of Moderate Congestive Heart Failure","status":"WITHDRAWN","sponsor":"University of New Mexico","startDate":"2008-11","conditions":"Heart Failure","enrollment":""},{"nctId":"NCT04706546","phase":"NA","title":"Hemodynamic Effects During Exercise in Patients With Pulmonary Hypertension Receiving Sildenafil","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2021-02-01","conditions":"Hypertension, Pulmonary","enrollment":24},{"nctId":"NCT04704440","phase":"NA","title":"Effects of Normobaric Hypoxia During Exercise in Patients With Pulmonary Hypertension With/Without Sildenafil","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2021-02-01","conditions":"Hypertension, Pulmonary","enrollment":24},{"nctId":"NCT04697862","phase":"NA","title":"Effects of Normobaric Hypoxia During Exercise in Patients With Pulmonary Hypertension Receiving Sildenafil","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2021-02-01","conditions":"Hypertension, Pulmonary","enrollment":24},{"nctId":"NCT04715113","phase":"NA","title":"Blood Markers Predict Effect of Normobaric Hypoxia at Rest and During Exercise in Patients With Pulmonary Hypertension","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2021-02-01","conditions":"Hypertension, Pulmonary","enrollment":24},{"nctId":"NCT05846906","phase":"PHASE2, PHASE3","title":"Effect of Oral Sildenafil Citrate on Improvement of Endometrial Thickness","status":"COMPLETED","sponsor":"Beni-Suef University","startDate":"2021-10-01","conditions":"Infertility, Female","enrollment":130},{"nctId":"NCT03997097","phase":"PHASE3","title":"Efficacy of Phosphodiesterase-type 5 Inhibitors in Patients With Univentricular Congenital Heart Disease","status":"WITHDRAWN","sponsor":"University Hospital, Montpellier","startDate":"2023-06-01","conditions":"Single-ventricle, Pulmonary Hypertension, Univentricular Heart","enrollment":""},{"nctId":"NCT05753098","phase":"PHASE4","title":"Effect of Sildenafil Citrate Compared to Estrogen as Adjuvant Therapy for Unexplained Infertility","status":"COMPLETED","sponsor":"Beni-Suef University","startDate":"2021-01-15","conditions":"Subfertility, Female","enrollment":148},{"nctId":"NCT05546125","phase":"","title":"a Non-interventional Study of Sildenafil in the Treatment of Pulmonary Arterial Hypertension (PAH) in Adults From China","status":"COMPLETED","sponsor":"Pfizer Pharmaceuticals Ltd.","startDate":"2021-12-23","conditions":"Pulmonary Arterial Hypertension (PAH)","enrollment":100},{"nctId":"NCT05669885","phase":"NA","title":"Hypersensitivity to Phosphodiesterase 5 Inhibition in Post-Traumatic Headache","status":"UNKNOWN","sponsor":"Danish Headache Center","startDate":"2023-01-02","conditions":"Post-Traumatic Headache","enrollment":21},{"nctId":"NCT04325243","phase":"PHASE4","title":"Sildenafil Citrate and Intrapartum Fetal Distress","status":"COMPLETED","sponsor":"Assiut University","startDate":"2020-09-01","conditions":"Fetal Distress","enrollment":410}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":354,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Sildenafil (Viagra)","genericName":"Sildenafil (Viagra)","companyName":"Charles Drew University of Medicine and Science","companyId":"charles-drew-university-of-medicine-and-science","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Sildenafil inhibits phosphodiesterase-5 (PDE-5) in the corpus cavernosum, increasing cyclic GMP levels and promoting smooth muscle relaxation and vasodilation. Used for Erectile dysfunction, Pulmonary arterial hypertension, Benign prostatic hyperplasia symptoms.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}